Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
Held every two years, the Vitiligo International Symposium (VIS) aims to expedite vitiligo therapy development. This event focuses on the latest breakthrough research and best practices relating to vitiligo management.
Traditionally, the VIS consists of informative podium sessions on a range of scientific issues from around the world, combined with clinical reports featuring proven techniques and novel observations, and additional workshops.
The 2020 Symposium is hosted in Bangalore, one of the best conference and touristic destinations in India.
The detailed program will be available soon.
WHEN: December 4-6, 2020
WHERE: TAJ Bangalore, India
Hope to see you in Bangalore in December 2020!
- Polypodium leucotomos as an adjunct treatment for vitiligo?
Extracts of the tropical fern Polypodium leucotomos appear to have beneficial properties for the vitiligious skin. Polypodium leucotomos (also classified as Polypodium aureum) a...
- Is there a special diet for vitiligo?
In short, no. Some people find that certain foods may worsen their vitiligo symptoms or that others may improve their skin condition. We found no scientific evidence that a sp...
- Does halo nevi affect vitiligo development?
Halo nevi — nevi with an depigmented circle around it, usually on the trunk — are about 10x more common in vitiligo patients than in the general population, especially in childr...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.Copyright (C) Bodolóczki Júlia
By taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.